All tenders
75A50324C00006

Anthim (Obiltoxaximab) Medical Procurement

Office of Assistant Secretary for Preparedness and Response · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number
75A50324C00006
Government level
Federal
Solicitation type
Other
Title
Anthim (Obiltoxaximab) Medical Procurement
Source ID
usa-75A50324C00006

Details

Location
United States

Summary

Contract for Anthim (Obiltoxaximab), a specialized medical treatment, awarded to Elusys Therapeutics Inc. This procurement supports emergency medical preparedness and response capabilities.

Description

ANTHIM (OBILTOXAXIMAB) Awarded to: ELUSYS THERAPEUTICS INC Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT

Dates

Publication
2024/05/01 12:00:00 AM UTC
Closing date
2028/12/31 12:00:00 AM UTC

Estimated value

$124.5M USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-07-10, 9:18:58 p.m.

Data refreshed every 2 hours